KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $3.4 billion.

  • Amgen's Other Operating Expenses rose 88.73% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 billion, marking a year-over-year increase of 321.84%. This contributed to the annual value of $13.1 billion for FY2024, which is 4047.16% up from last year.
  • As of Q3 2025, Amgen's Other Operating Expenses stood at $3.4 billion, which was up 88.73% from $3.1 billion recorded in Q2 2025.
  • Amgen's 5-year Other Operating Expenses high stood at $3.8 billion for Q1 2025, and its period low was $1.6 billion during Q1 2021.
  • In the last 5 years, Amgen's Other Operating Expenses had a median value of $2.4 billion in 2023 and averaged $2.5 billion.
  • In the last 5 years, Amgen's Other Operating Expenses skyrocketed by 9901.48% in 2021 and then plummeted by 3650.99% in 2022.
  • Quarter analysis of 5 years shows Amgen's Other Operating Expenses stood at $1.8 billion in 2021, then dropped by 3.17% to $1.7 billion in 2022, then surged by 81.96% to $3.1 billion in 2023, then increased by 1.8% to $3.2 billion in 2024, then grew by 7.5% to $3.4 billion in 2025.
  • Its Other Operating Expenses stands at $3.4 billion for Q3 2025, versus $3.1 billion for Q2 2025 and $3.8 billion for Q1 2025.